SEC 13F Intelligence

Managers / Q2 2020 · view latest →

Telemetry Investments, L.L.C.

CIK 0001537055 · 152 WEST 36TH STREET, ROOM 402, NEW YORK, NY, 10018-8765 · 212-425-9700

Reported Value
$37M
Q2 2020
Positions
65
Filings on Record
17
2019–present window
Filed
Aug 14, 2020
original filing

Summary

Telemetry Investments, L.L.C. reported $37M in U.S.-listed holdings across 65 positions for Q2 2020.

Its largest position, XLU, represents 5.4% of the portfolio.

Compared with Q1 2020, the fund opened 27 new positions and exited 16.

Portfolio Metrics

Turnover
+38.3%
vs prior filed quarter
Top-10 Concentration
+39.0%
share of reported value
Largest Position
+5.4%
Select Sector Spdr Tr
New / Exited
27 / 16
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $157MQ4 ’18Q1 ’19: $197MQ2 ’19: $129MQ2 ’19Q3 ’19: $35MQ4 ’19: $30MQ4 ’19Q1 ’20: $29MQ2 ’20: $37MQ2 ’20Q3 ’20: $46MQ4 ’20: $59MQ4 ’20Q1 ’21: $88MQ2 ’21: $73MQ2 ’21Q3 ’21: $74MQ4 ’21: $78MQ4 ’21Q1 ’22: $63MQ2 ’22: $84MQ2 ’22Q3 ’22: $78Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 66.9%ETP: 19.6%Other: 10.8%ADR: 2.5%REIT: 0.2%
  • Common Stock · 66.9% · $25M
  • ETP · 19.6% · $7M
  • Other · 10.8% · $4M
  • ADR · 2.5% · $931,000
  • REIT · 0.2% · $66,000

Quarter-over-Quarter Changes full breakdown →

vs Q1 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ETRAE TRADE FINANCIAL CORPNEW+34.0K34.0K+$2M$2M
REGNREGENERON PHARMACEUTICALSNEW+2.5K2.5K+$2M$2M
XLUSELECT SECTOR SPDR TRNEW+25.0K25.0K+$1M$1M
FEZSPDR INDEX SHS FDSNEW+25.0K25.0K+$888,000$888,000
EUFNISHARES TRNEW+60.0K60.0K+$854,000$854,000
EL PASO ELEC CONEW+11.7K11.7K+$784,000$784,000
DELPHI TECHNOLOGIES PLNEW+53.5K53.5K+$760,000$760,000
LMEURLEGG MASON INCNEW+14.8K14.8K+$735,000$735,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2020

54 positions
#IssuerClass% PortfolioValueShares
1XLUSELECT SECTOR SPDR TRSBI INT-UTILS · SBI INT-FINL5.40%$2M50.0K
2KDMNKADMON HLDGS INChistory →COM4.75%$2M342.0K
3ETRAE TRADE FINANCIAL CORPhistory →COM NEW4.59%$2M34.0K
4BELLEROPHON THERAPEUTICS INCCOM NEW4.26%$2M125.0K
5REGNREGENERON PHARMACEUTICALShistory →COM4.23%$2M2.5K
6EIGER BIOPHARMACEUTICALS INCCOM4.04%$1M155.0K
7GDXVANECK VECTORS ETF TRGOLD MINERS ETF · JR GOLD MINERS E3.14%$1M28.0K
8EUFNISHARES TRMSCI EURO FL ETF · MSCI INDIA ETF3.11%$1M70.0K
9AFFIMED N VCOM2.87%$1M229.3K
10ACIAACACIA COMMUNICATIONS INChistory →COM2.55%$941,00014.0K
11FEZSPDR INDEX SHS FDShistory →EURO STOXX 502.41%$888,00025.0K
12BACBK OF AMERICA CORPhistory →COM2.29%$845,00035.6K
13ADMAADMA BIOLOGICS INChistory →COM2.23%$821,000280.1K
14EL PASO ELEC COCOM NEW2.13%$784,00011.7K
15DISDISNEY WALT COhistory →COM DISNEY2.09%$769,0006.9K
16ACRSACLARIS THERAPEUTICS INChistory →COM2.09%$768,000473.9K
17DELPHI TECHNOLOGIES PLSHS2.06%$760,00053.5K
18GLDSPDR GOLD TRhistory →GOLD SHS2.04%$753,0004.5K
19FITBIT INCCL A2.04%$752,000116.4K
20EWZISHARES INCMSCI BRAZIL ETF · MSCI MEXICO ETF2.04%$750,00025.0K
21LMEURLEGG MASON INChistory →COM2.00%$735,00014.8K
22EXMOCEXXON MOBIL CORPhistory →COM1.98%$729,00016.3K
23MUSTANG BIO INCCOM1.98%$729,000229.2K
24WTWWILLIS TOWERS WATSON PLC LTDhistory →SHS1.50%$551,0002.8K
25TIFFANY & CO NEWCOM1.49%$549,0004.5K
26XMESPDR SER TRhistory →S&P METALS MNG1.44%$530,00025.0K
27CCITIGROUP INChistory →COM NEW1.39%$511,00010.0K
28LOGMEIN INCCOM1.38%$509,0006.0K
29VRAYQVIEWRAY INChistory →COM1.26%$464,000207.1K
30NEMNEWMONT CORPhistory →COM1.23%$454,0007.4K
31ERICERICSSONhistory →ADR B SEK 101.13%$418,00045.0K
32RIGEL PHARMACEUTICALS INCCOM NEW1.12%$413,000225.5K
33GLOBALSTAR INCCOM1.08%$397,0001.22M
34ETF MANAGERS TRETFMG ALTR HRVST1.05%$386,00030.0K
35WRIGHT MED GROUP N VORD SHS0.97%$357,00012.0K
36PARATEK PHARMACEUTICALS INCCOM0.92%$337,00064.5K
37ADSWADVANCED DISP SVCS INC DELCOM0.77%$284,0009.4K
38SANBANCO SANTANDER S.A.ADR0.75%$277,000115.0K
39FSLRFIRST SOLAR INCCOM0.67%$248,0005.0K
40TRACON PHARMACEUTICALS INCCOM NEW0.67%$246,000125.4K
4158 COM INCSPON ADR REP A0.64%$236,0004.4K
42ALXNALEXION PHARMACEUTICALS INCCOM0.61%$224,0002.0K
43TWITTER INCCOM0.59%$218,0007.3K
44XTNTXTANT MED HLDGS INCCOM NEW0.50%$185,000205.6K
45CBBCINCINNATI BELL INC NEWCOM NEW0.50%$183,00012.3K
46VERASTEM INCCOM0.46%$169,00098.0K
47MEET GROUP INCCOM0.29%$106,00017.0K
48GILAT SATELLITE NETWORKS LTDSHS NEW0.24%$89,00014.0K
49CENTRAL EUROPEAN MEDIA ENTRPCL A NEW0.19%$71,00020.0K
50CONDOR HOSPITALITY TR INCCOM NEW0.18%$66,00016.2K
51ENDOLOGIX INCCOM NEW0.17%$63,00078.5K
52ZOSANO PHARMA CORPCOM NEW0.16%$59,00069.0K
53FORTRESS BIOTECH INCCOM0.15%$55,00020.4K
54ROSEHILL RES INCCL A · *W EXP 04/27/2020.13%$48,00099.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2022Under review146Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$78M177Nov 17, 202213F-HRchanges · EDGAR ↗
Q2 2022$84M177Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$63M165May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$78M178Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$74M160Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$73M139Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$88M126May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$59M89Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$46M73Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$37M65Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$29M54May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$30M41Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$35M53Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$129M82Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$197M101May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$157M136Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.